NASDAQ · Analyst Forecast

VivoSim Labs, Inc. (VIVS) Stock Forecast & Price Target

$0.12 NASDAQ: VIVS Market Cap $1.99M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering VivoSim Labs, Inc. (VIVS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For VivoSim Labs, Inc., analysts forecast revenue falling from $5.20M in 2022 to $232,000 in 2027; the average estimate for 2027 earnings per share is −$9.00; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2022$5.20M$5.20M$5.20M1
2023$6.55M$6.55M$6.55M1
2024$444,000$444,000$444,0001
2025$170,000$170,000$170,0001
2026$201,000$201,000$201,0001
2027$232,000$232,000$232,0001

Earnings per share forecast

YearLowAverageHighAnalysts
2022−$45.60−$45.60−$45.601
2023−$55.20−$55.20−$55.201
2024−$16.92−$16.92−$16.921
2025−$9.24−$9.24−$9.241
2026−$9.00−$9.00−$9.001
2027−$9.00−$9.00−$9.001

VivoSim Labs, Inc. (VIVS) forecast — frequently asked questions

What are analysts forecasting for VivoSim Labs, Inc.'s earnings?

The average analyst estimate for VivoSim Labs, Inc. (VIVS) earnings per share in 2027 is -9.00, with individual estimates between -9.00 and -9.00.

How much revenue is VivoSim Labs, Inc. expected to make?

Analysts forecast VivoSim Labs, Inc. (VIVS) revenue of $232,000 in 2027, based on 1 published estimates.

How many analysts cover VIVS?

1 analyst contribute estimates for VivoSim Labs, Inc. (VIVS). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.